Gastrointestinal stromal tumors (GIST)
Conditions
Interventions
Gastrointestinal stromal tumor patient group:None
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age>=18 years old; 2.The diagnosis of gastrointestinal stromal tumor was confirmed through pathological analysis and imaging examinations; 3.Imatinib for adjuvant therapy; 4.At least three imatinib concentrations can be obtained; 5.The available follow-up period should be at least 24 months;
Exclusion criteria
Exclusion criteria: 1.Imatinib for either neoadjuvant or palliative therapy; 2.Concomitant drugs that significantly affect the pharmacokinetics of IM (such as ketoconazole, itraconazole, erythromycin, clarithromycin, rifampicin, phenobarbital, phenytoin sodium, carbamazepine and oxcarbazepine); 3.Lack of relevant information for this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease-Free Survival; | — |
Countries
China
Contacts
Public ContactZhou Hong
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed